Chengdu Kanghua Biological Products Co., Ltd. (referred to as "Kangh"), established in 2004, stands as one of the 13 enterprises in Chengdu Economic and Technological Development Zone with full vaccine production capacity. Kangh's core business encompasses research, development, production, sales, and technical services related to biological products for prevention. The company's product portfolio includes Group ACYW135 Mening...
Chengdu Kanghua Biological Products Co., Ltd. (referred to as "Kangh"), established in 2004, stands as one of the 13 enterprises in Chengdu Economic and Technological Development Zone with full vaccine production capacity. Kangh's core business encompasses research, development, production, sales, and technical services related to biological products for prevention. The company's product portfolio includes Group ACYW135 Meningococcal Polysaccharide Vaccine-Maikexin and Rabies Vaccine (human diploid cell) for Human Use in freeze-dried form (HDCV).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.